These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 14500492)

  • 1. Construction and functional activities of chimeric mouse-human immunoglobulin G and immunoglobulin M antibodies against the Neisseria meningitidis PorA P1.7 and P1.16 epitopes.
    Michaelsen TE; Ihle Ø; Beckstrøm KJ; Herstad TK; Kolberg J; Høiby EA; Aase A
    Infect Immun; 2003 Oct; 71(10):5714-23. PubMed ID: 14500492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding properties and anti-bacterial activities of V-region identical, human IgG and IgM antibodies, against group B Neisseria meningitidis.
    Michaelsen TE; Ihle Ø; Beckstrøm KJ; Herstad TK; Sandin RH; Kolberg J; Aase A
    Biochem Soc Trans; 2003 Oct; 31(Pt 5):1032-5. PubMed ID: 14505474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cloning, sequencing and expression of immunoglobulin variable regions of murine monoclonal antibodies specific for the P1.7 and P1.16 PorA protein loops of Neisseria meningitidis.
    Ihle Ø; Beckstrøm KJ; Michaelsen TE
    Scand J Immunol; 2003 May; 57(5):453-62. PubMed ID: 12753502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The four mouse IgG isotypes differ extensively in bactericidal and opsonophagocytic activity when reacting with the P1.16 epitope on the outer membrane PorA protein of Neisseria meningitidis.
    Michaelsen TE; Kolberg J; Aase A; Herstad TK; Høiby EA
    Scand J Immunol; 2004 Jan; 59(1):34-9. PubMed ID: 14723619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human IgG1, IgG3, and IgG3 Hinge-Truncated Mutants Show Different Protection Capabilities against Meningococci Depending on the Target Antigen and Epitope Specificity.
    Giuntini S; Granoff DM; Beernink PT; Ihle O; Bratlie D; Michaelsen TE
    Clin Vaccine Immunol; 2016 Aug; 23(8):698-706. PubMed ID: 27307451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitidis.
    Wang J; Jarvis GA; Achtman M; Rosenqvist E; Michaelsen TE; Aase A; Griffiss JM
    Infect Immun; 2000 Apr; 68(4):1871-8. PubMed ID: 10722576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of human and murine monoclonal IgGs specific for the P1.7 PorA protein of Neisseria meningitidis.
    Delvig A; Jahn S; Kusecek B; Heckels JE; Rosenqvist E; Høiby EA; Michaelsen TE; Achtman M
    Mol Immunol; 1994 Nov; 31(16):1257-67. PubMed ID: 7526159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines.
    Rouppe van der Voort EM; Kuipers B; Brugghe HF; van Unen LM; Timmermans HA; Hoogerhout P; Poolman JT
    FEMS Immunol Med Microbiol; 1997 Mar; 17(3):139-48. PubMed ID: 9093834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine monoclonal antibodies to PorA of Neisseria meningitidis show reduced protective activity in vivo against B:15:P1.7,16 subtype variants in an infant rat infection model.
    Toropainen M; Saarinen L; van der Ley P; Kuipers B; Käyhty H
    Microb Pathog; 2001 Mar; 30(3):139-48. PubMed ID: 11273739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human bactericidal antibodies against PorA P1.7,16 induced with a hexavalent meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van der Ley P; van der Biezen J; George S; Tunnela O; van Dijken H; Kuipers B; Poolman J
    Infect Immun; 1996 Jul; 64(7):2745-51. PubMed ID: 8698504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal antibody recognition of a PorA epitope of Neisseria meningitidis: crystal structure of a Fab fragment in complex with a fluorescein-conjugated peptide.
    van den Elsen JM; Herron JN; Hoogerhout P; Poolman JT; Boel E; Logtenberg T; Wilting J; Crommelin DJ; Kroon J; Gros P
    Proteins; 1997 Sep; 29(1):113-25. PubMed ID: 9294871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody specificities and effect of meningococcal carriage in icelandic teenagers receiving the Norwegian serogroup B outer membrane vesicle vaccine.
    Wedege E; Kuipers B; Bolstad K; van Dijken H; Frøholm LO; Vermont C; Caugant DA; van den Dobbelsteen G
    Infect Immun; 2003 Jul; 71(7):3775-81. PubMed ID: 12819059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of transformation to construct antigenic hybrids of the class 1 outer membrane protein in Neisseria meningitidis.
    van der Ley P; van der Biezen J; Hohenstein P; Peeters C; Poolman JT
    Infect Immun; 1993 Oct; 61(10):4217-24. PubMed ID: 7691745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay.
    van den Elsen JM; van Pomeren E; Poolman JT; Wilting J; Herron JN; Crommelin DJ
    Anal Biochem; 1997 May; 247(2):382-8. PubMed ID: 9177702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of a murine monoclonal antibody specific for the P1.15 PorA proteins from vaccine strain B:4,7:P1.19,15 of Neisseria meningitidis.
    Pérez ME; Barberá R; Domínguez F; Otero O; Gutiérrez M; Falero-Diaz G; Sotolongo F; Sierra G
    Hybridoma (Larchmt); 2006 Aug; 25(4):243-7. PubMed ID: 16934022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PorA-specific differences in antibody avidity after vaccination with a hexavalent Men B outer membrane vesicle vaccine in toddlers and school children.
    Vermont CL; Van Dijken HH; De Groot R; Van Alphen L; Van Den Dobbelsteen GP
    Vaccine; 2004 Aug; 22(23-24):3008-13. PubMed ID: 15297049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation and formation of the membrane attack complex on serogroup B Neisseria meningitidis in the presence or absence of serum bactericidal activity.
    Drogari-Apiranthitou M; Kuijper EJ; Dekker N; Dankert J
    Infect Immun; 2002 Jul; 70(7):3752-8. PubMed ID: 12065518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to meningococcal class 1 outer-membrane protein and its variable regions in patients with systemic meningococcal disease.
    Idänpään-Heikkilä I; Høiby EA; Chattopadhyay P; Airaksinen U; Michaelsen TM; Wedege E
    J Med Microbiol; 1995 Nov; 43(5):335-43. PubMed ID: 7562997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mimetic antigen eliciting protective antibody to Neisseria meningitidis.
    Granoff DM; Moe GR; Giuliani MM; Adu-Bobie J; Santini L; Brunelli B; Piccinetti F; Zuno-Mitchell P; Lee SS; Neri P; Bracci L; Lozzi L; Rappuoli R
    J Immunol; 2001 Dec; 167(11):6487-96. PubMed ID: 11714816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human B- and T-cell responses after immunization with a hexavalent PorA meningococcal outer membrane vesicle vaccine.
    van der Voort ER; van Dijken H; Kuipers B; van der Biezen J; van der Ley P; Meylis J; Claassen I; Poolman J
    Infect Immun; 1997 Dec; 65(12):5184-90. PubMed ID: 9393814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.